Prognosis of early‐stage HFpEF in the community‐dwelling elderly: The Northern Shanghai Study

Weilun Meng,Haotian Yang,Zhongyuan Ren,Jiawen Wu,Yixing Zheng,Song Zhao,Chong Xu,Rusitanmujiang Maimaitiaili,Jiamin Tang,Shikai Yu,Jing Xiong,Chen Chi,Yawei Xu,Yi Zhang
DOI: https://doi.org/10.1002/ehf2.15060
2024-09-14
ESC Heart Failure
Abstract:Objective Heart failure with preserved ejection fraction (HFpEF) is a growing concern among the elderly population, significantly impacting morbidity and mortality rates. This study aimed to screen and investigate the characteristics and prognosis of early‐stage HFpEF in the elderly. Methods A total of 1789 community‐dwelling individuals aged over 65 from northern Shanghai were enrolled. According to American Heart Association (AHA) guidelines, participants were classified into four groups: HFpEF stage 0, HFpEF stage A, HFpEF stage B and HFpEF stage C. Major endpoints included major adverse cardiovascular events (MACEs), all‐cause death and cardiovascular death. Results After a mean follow‐up period of 7.10 ± 1.27 years, 1623 elderly subjects were included [HFpEF stage 0 (10.3%), HFpEF stage A (16.3%), HFpEF stage B (60.6%) and HFpEF stage C (12.8%)]. Patients with HFpEF stage A, HFpEF stage B and HFpEF stage C exhibited more MACEs than those in HFpEF stage 0 (P
cardiac & cardiovascular systems
What problem does this paper attempt to address?